Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study

Alzheimer's and Dementia

Volumn 13, Issue 6, 2017, Pages 634-643

  Wardlaw, Joanna M ^a   Makin, Stephen J ^a   Valdés Hernández, Maria C ^a   Armitage, Paul A ^b   Heye, Anna K ^a   Chappell, Francesca M ^a   Muñoz Maniega, Susana ^a   Sakka, Eleni ^a   Shuler, Kirsten ^a   Dennis, Martin S ^a   Thrippleton, Michael J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Blood brain barrier; Dementia; Small vessel disease; Stroke; White matter hyperintensities

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INTERSTITIAL FLUID; CEREBROVASCULAR ACCIDENT; COGNITION; COHORT ANALYSIS; CORTICAL ISCHEMIC STROKE; DEMENTIA; HUMAN; HYPERTENSION; LACUNAR STROKE; MAJOR CLINICAL STUDY; NEUROIMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; TISSUE SPECIFICITY; VERY ELDERLY; WHITE MATTER;

EID: 85012939147     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2016.09.006     Document Type: Article

References (59)

1. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2013), 2095–2128.
2. Iadecola, C., The pathobiology of vascular dementia. Neuron 80 (2013), 844–866.
3. Makin, S., Turpin, S., Dennis, M., Wardlaw, J., Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke sub-types. J Neurol Neurosurg Psychiatry 84 (2013), 893–900.
4. Valdes Hernandez, M.C., Maconick, L.C., Munoz Maniega, S., Wang, X., Wiseman, S., Armitage, P.A., et al. A comparison of location of acute symptomatic versus ‘silent’ small vessel lesions. Int J Stroke 10 (2015), 1044–1050.
5. Debette, S., Markus, H.S., The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ, 341, 2010, c3666.
6. Vermeer, S.E., Longstreth, W.T. Jr., Koudstaal, P.J., Silent brain infarcts: a systematic review. Lancet Neurol 6 (2007), 611–619.
7. Cordonnier, C., Al-Shahi Salman, R., Wardlaw, J., Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 130 (2007), 1988–2003.
8. Staals, J., Booth, T., Morris, Z., Bastin, M.E., Gow, A.J., Corley, J., et al. Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiol Aging 36 (2015), 2806–2811.
9. Snowdon, D.A., Greiner, L.H., Mortimer, J.A., Riley, K.P., Greiner, P.A., Markesbery, W.R., Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277 (1997), 813–817.
10. Matthews, F.E., Brayne, C., Lowe, J., McKeith, I., Wharton, S.B., Ince, P., Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med, 6, 2009, e1000180.
11. Smallwood, A., Oulhaj, A., Joachim, C., Christie, S., Sloan, C., Smith, A.D., et al. Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol Appl Neurobiol 38 (2012), 337–343.
12. Tosto, G., Zimmerman, M.E., Carmichael, O.T., Brickman, A.M., Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities. JAMA Neurol 71 (2014), 872–877.
13. Norton, S., Matthews, F.E., Barnes, D.E., Yaffe, K., Brayne, C., Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol 13 (2014), 788–794.
14. Ngandu, T., Lehtisalo, J., Solomon, A., Levalahti, E., Ahtiluoto, S., Antikainen, R., et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385 (2015), 2255–2263.
15. Sposato, L.A., Kapral, M.K., Fang, J., Gill, S.S., Hackam, D.G., Cipriano, L.E., et al. Declining incidence of stroke and dementia: coincidence or prevention opportunity?. JAMA Neurol 72 (2015), 1529–1531.
16. Pearce, L.A., McClure, L.A., Anderson, D.C., Jacova, C., Sharma, M., Hart, R.G., et al. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Lancet Neurol 13 (2014), 1177–1185.
17. The SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 367 (2012), 817–825.
18. Thoonsen, H., Richard, E., Bentham, P., Gray, R., van Geloven, N., De Haan, R.J., et al. Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?. Stroke 41 (2010), 2690–2692.
19. Wardlaw, J.M., Smith, C., Dichgans, M., Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 12 (2013), 483–497.
20. Wharton, S.B., Simpson, J.E., Brayne, C., Ince, P.G., Age-associated white matter lesions: The MRC Cognitive Function and Ageing Study. Brain Pathol 25 (2015), 35–43.
21. Bath, P.M., Wardlaw, J.M., Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. Int J Stroke 10 (2015), 469–478.
22. Wardlaw, J.M., Sandercock, P.A., Dennis, M.S., Starr, J., Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?. Stroke 34 (2003), 806–812.
23. de la Torre, J., The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond. Neurodegener Dis 7 (2010), 116–121.
24. Bailey, E.L., Smith, C., Sudlow, C.L., Wardlaw, J.M., Pathology of lacunar ischaemic stroke in humans—a systematic review. Brain Pathol 22 (2012), 583–591.
25. Black, S., Gao, F., Bilbao, J., Understanding white matter disease. Imaging-pathological correlations in vascular cognitive impairment. Stroke 40 (2009), S48–S52.
26. Biron, K.E., Dickstein, D.L., Gopaul, R., Jefferies, W.A., Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. PLoS One, 6, 2011, e23789.
27. Kolstoe, S.E., Ridha, B.H., Bellotti, V., Wang, N., Robinson, C.V., Crutch, S.J., et al. Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component. Proc Natl Acad Sci U S A 106 (2009), 7619–7623.
28. Farrall, A.J., Wardlaw, J.M., Blood brain barrier: ageing and microvascular disease—systemic review and meta-analysis. Neurobiol Aging 30 (2009), 337–352.
29. Starr, J.M., Wardlaw, J., Ferguson, K., MacLullich, A., Deary, I.J., Marshall, I., Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 74 (2003), 70–76.
30. Wardlaw, J.M., Doubal, F., Armitage, P., Chappell, F., Carpenter, T., Maniega, S.M., et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 65 (2009), 194–202.
31. Topakian, R., Barrick, T.R., Howe, F.A., Markus, H.S., Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 81 (2010), 192–197.
32. Taheri, S., Gasparovic, C., Huisa, B.N., Adair, J.C., Edmonds, E., Prestopnik, J., et al. Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 42 (2011), 2158–2163.
33. Kalaria, R.N., The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann N Y Acad Sci 893 (1999), 113–125.
34. Starr, J.M., Farrall, A.J., Armitage, P., McGurn, B., Wardlaw, J., Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study. Psychiatry Res 171 (2009), 232–241.
35. Montagne, A., Barnes, S.R., Sweeney, M.D., Halliday, M.R., Sagare, A.P., Zhao, Z., et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85 (2015), 296–302.
36. Heye, A.K., Culling, R.D., Valdes Hernandez, M.C., Thrippleton, M.J., Wardlaw, J.M., Assessment of blood–brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Neuroimage Clin 6 (2014), 262–274.
37. Heye, A.K., Thrippleton, M.J., Armitage, P.A., Valdes Hernandez, M.C., Makin, S.D., Glatz, A., et al. Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability. Neuroimage 125 (2016), 446–455.
38. Maillard, P., Seshadri, S., Beiser, A., Himali, J.J., Au, R., Fletcher, E., et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol 11 (2012), 1039–1047.
39. Jackson, C.A., Hutchison, A., Dennis, M.S., Wardlaw, J.M., Lindgren, A., Norrving, B., et al. Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy?. Stroke 41 (2010), 624–629.
40. Bamford, J., Sandercock, P., Dennis, M., Burn, J., Warlow, C., Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991), 1521–1526.
41. Bamford, J., Sandercock, P., Dennis, M., Burn, J., Warlow, C., A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project—1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 53 (1990), 16–22.
42. Valdés Hernández, M., Armitage, P., Thrippleton, M.J., Chappell, F., Sandeman, E., Munoz Maniega, S., et al. Rationale, design and methodology of the image analysis protocol for studies of patients with cerebral small vessel disease and mild stroke. Brain Behav, 5, 2015, e00415.
43. Wardlaw, J.M., Smith, E.E., Biessels, G.J., Cordonnier, C., Fazekas, F., Frayne, R., et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: a united approach. Lancet Neurol 12 (2013), 822–838.
44. Armitage, P.A., Farrall, A.J., Carpenter, T.K., Doubal, F.N., Wardlaw, J.M., Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities. Magn Reson Imaging 29 (2011), 305–314.
45. Wardlaw, J.M., Bastin, M.E., Valdes Hernandez, M.C., Munoz Maniega, S., Royle, N.A., Morris, Z., et al. Brain aging, cognition in youth and old age and vascular disease in the Lothian Birth Cohort 1936: rationale, design and methodology of the imaging protocol. Int J Stroke 6 (2011), 547–559.
46. Valdes Hernandez, M.C., Ferguson, K.J., Chappell, F.M., Wardlaw, J.M., New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images. Eur Radiol 20 (2010), 1684–1691.
47. Munoz Maniega, S., Chappell, F.M., Valdes Hernandez, M.C., Armitage, P.A., Makin, S.D., Heye, A.K., et al. Integrity of normal-appearing white matter: influence of age, visible lesion burden and hypertension in patients with small vessel disease. J Cereb Blood Flow Metab 36 (2016), 264–274.
48. Munoz Maniega, S., Valdes Hernandez, M., Clayden, J.D., Royle, N.A., Murray, C., Morris, Z., et al. White matter hyperintensities and normal-appearing white matter integrity in the aging brain. Neurobiol Aging, 36, 2015, 909.
49. Barnes, S.R., Ng, T.S., Montagne, A., Law, M., Zlokovic, B.V., Jacobs, R.E., Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI. Magn Reson Med 75 (2016), 1967–1977.
50. Heye, A.K., Thrippleton, M.J., Chappell, F.M., Valdes Hernandez, M.C., Armitage, P.A., Makin, S.D., et al. Blood pressure and sodium: association with MRI markers in cerebral small vessel disease. J Cereb Blood Flow Metab 36 (2016), 264–274.
51. SPS3 Study Group, Benavente, O.R., Coffey, C.S., Conwit, R., Hart, R.G., McClure, L.A., et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 382 (2013), 507–515.
52. Maillard, P., Fletcher, E., Lockhart, S.N., Roach, A.E., Reed, B., Mungas, D., et al. White matter hyperintensities and their penumbra lie along a continuum of injury in the aging brain. Stroke 45 (2014), 1721–1726.
53. Huisa, B.N., Caprihan, A., Thompson, J., Prestopnik, J., Qualls, C.R., Rosenberg, G.A., Long-term blood-brain barrier permeability changes in Binswanger disease. Stroke 46 (2015), 2413–2418.
54. Lammie, G.A., Brannan, F., Wardlaw, J.M., Incomplete lacunar infarction (type 1b lacunes). Acta Neuropathol 96 (1998), 163–171.
55. Chen, A., Akinyemi, R.O., Hase, Y., Firbank, M.J., Ndung'u, M.N., Foster, V., et al. Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. Brain 139 (2016), 242–258.
56. Turner, S.T., Jack, C.R., Fornage, M., Mosley, T.H., Boerwinkle, E., de Andrade, M., Heritability of leukoaraiosis in hypertensive sibships. Hypertension 43 (2004), 483–487.
57. Verhaaren, B.F., Debette, S., Bis, J.C., Smith, J.A., Ikram, M.K., Adams, H.H., et al. Multi-ethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet 8 (2015), 398–409.
58. Lopez, L., Hill, W.D., Harris, S.E., Valdes Hernandez, M., Munoz Maniega, S., Bastin, M.E., et al. Genes from a translational analysis support a multifactorial nature of white matter hyperintensities. Stroke 46 (2015), 341–347.
59. Stevenson, S.F., Doubal, F.N., Shuler, K., Wardlaw, J.M., A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 41 (2010), e434–e442.